Saturday, February 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Quantum eMotion Secures NYSE American Listing, Sets New Ticker

Rodolfo Hanigan by Rodolfo Hanigan
February 21, 2026
in AI & Quantum Computing, IPOs, Penny Stocks, Tech & Software
0
Quantum eMotion Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Quantum eMotion Corp. has achieved a significant corporate milestone, receiving regulatory approval to list its common shares on the NYSE American exchange. This move grants the company enhanced access to U.S. capital markets, with trading anticipated to commence imminently. Shareholders are evaluating what this transition means for their holdings.

A New Trading Venue and Symbol

The company confirmed that NYSE American LLC has granted approval for the listing and trading of its common equity. Market activity is scheduled to begin at the exchange’s opening on or about Tuesday. The shares will be traded under the new ticker symbol “QNC”.

Management has framed this uplisting as a pivotal strategic action designed to broaden its shareholder base and strengthen its profile among U.S. investors.

Transition from OTC Markets

Upon the effectiveness of the NYSE American listing, the trading of Quantum eMotion’s common stock on the OTCQB Venture Market will be terminated. The company will maintain its existing listings on two other exchanges concurrently:

Should investors sell immediately? Or is it worth buying Quantum eMotion?

  • TSX Venture Exchange (Symbol: QNC)
  • Frankfurt Stock Exchange (Symbol: 34Q0)

According to the firm’s announcement, current shareholders are not required to take any action ahead of the expected U.S. market debut. Investors who previously purchased shares via the OTCQB are advised to verify that their brokerage accounts correctly reflect the holdings under the appropriate new trading symbol.

Regulatory Pathway to the Listing

This listing follows a formal regulatory process initiated earlier this year. In January, Quantum eMotion filed a Form 40-F registration statement with U.S. authorities. This document serves as the standard method for Canadian issuers to register securities for trading on U.S. exchanges with the relevant regulators.

The immediate next step is the anticipated commencement of trading on or around Tuesday on the NYSE American platform. Concurrently, the company’s shares will cease to be quoted on the OTCQB.

Ad

Quantum eMotion Stock: Buy or Sell?! New Quantum eMotion Analysis from February 21 delivers the answer:

The latest Quantum eMotion figures speak for themselves: Urgent action needed for Quantum eMotion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 21.

Quantum eMotion: Buy or sell? Read more here...

Tags: Quantum eMotion
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Inspire Veterinary Partners Stock
Analysis

Assessing Inspire Veterinary Partners’ Strategic Execution

February 21, 2026
IO Biotech Stock
Analysis

Navigating the Funding Challenge: IO Biotech’s Critical Juncture

February 21, 2026
Bgc Group Inc A Stock
Analysis

BGC Group’s Strategic Pivot: Betting Big on Digital Brokerage Platforms

February 21, 2026
Next Post
Tenneco Stock

Tenneco's Indian Arm Charts a Course with Robust Orders and Strategic Moves

Community West Bancshares Stock

Leadership Shifts and Insider Buying Precede Key Merger for Community West Bancshares

Onestream Stock

Onestream Acquisition Faces Regulatory and Shareholder Scrutiny

Recommended

MicroStrategy Stock

Market Stunned as China Renaissance Backs MicroStrategy Amid Bitcoin Accumulation

4 months ago
Ocugen Stock

Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?

3 months ago
Stereotaxis Stock

Stereotaxis Stock: A Critical Juncture Approaches

3 months ago
Films and camera

HCA Healthcare Reports Impressive Financial Results and Optimistic Outlook for 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Navigating the Funding Challenge: IO Biotech’s Critical Juncture

The Next Chapter for Ruth’s Chris: A Look Inside Darden’s Portfolio

Ryan Specialty Holdings Charts a New Course with Restructuring and Capital Return

A Factor-Based Approach to Mid-Cap Investing Gains Relevance

BGC Group’s Strategic Pivot: Betting Big on Digital Brokerage Platforms

The Constitutional Counterpunch, A 150-Day Sprint, and Walmart’s Warning

Trending

BOK Stock
Analysis

Leadership Transition at BOK Financial Amid Record Performance

by Kennethcix
February 21, 2026
0

BOK Financial is navigating a significant leadership transition as it posts record financial results. The institution is...

Complete Solaria Stock

Navigating the Regulatory Maze: A Critical Period for Complete Solaria

February 21, 2026
Inspire Veterinary Partners Stock

Assessing Inspire Veterinary Partners’ Strategic Execution

February 21, 2026
IO Biotech Stock

Navigating the Funding Challenge: IO Biotech’s Critical Juncture

February 21, 2026
Ruth's Hospitality Stock

The Next Chapter for Ruth’s Chris: A Look Inside Darden’s Portfolio

February 21, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Leadership Transition at BOK Financial Amid Record Performance
  • Navigating the Regulatory Maze: A Critical Period for Complete Solaria
  • Assessing Inspire Veterinary Partners’ Strategic Execution

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com